ArticleEuropean journal of trauma and emergency surgery : official publication of the European Trauma Society2025
Anatomical implant region - a critical determinant for the osteogenic potency of small extracellular vesicles and rhBMP-2.
Article in European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exercise‑induced exosomal noncoding RNAs: Molecular signaling cascades in bone remodeling and translational applications in sports‑related bone injuries (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMechanical stabilization is crucial for bone healing, yet complex fractures, particularly osteoporotic or comminuted, remain challenging due to impaired implant osseointegration, resulting in implant loosening or non-unions. This study investigated whether co-application of small extracellular vesicles (sEVs) derived from human umbilical cord mesenchymal stromal cells (hUC-MSC-sEVs) with a low dose of recombinant human bone morphogenetic protein 2 (rhBMP-2) could enhance screw implant osseointegration.
methodsA novel small animal model was established to evaluate the effect of anatomical femur regions on screw integration. Six weeks postoperatively, bone formation and bone-implant contact were assessed by micro-computed tomography and descriptive histology. Biomechanical stability was determined using pull-out tests.
resultsOutcomes differed significantly between the proximal and distal implant locations, with no improvements in osseointegration observed in the distal region. In the proximal region, application of hUC-MSC-sEVs alone did not significantly improve osseointegration, whereas local application of 1.5 µg rhBMP-2 resulted in measurable biomechanical improvements. No additive or synergistic effects were observed when sEVs were co-administered with rhBMP-2. Descriptive histology supported these findings, demonstrating the most pronounced bone formation at the proximal site following rhBMP-2 treatment.
conclusionhUC-MSC-sEVs did not enhance screw implant osseointegration and slightly reduced new bone formation. In contrast, a low dose of rhBMP-2 (1.5 µg) promoted implant integration, with no additive effect when combined with sEVs. Notably, the osteogenic effect of rhBMP-2 was observed only at the proximal femoral site, indicating that anatomical location critically influences implant osseointegration. These findings highlight the importance of considering anatomical region when evaluating osteoinductive treatments and implant materials in small animal models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.